,,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['breast', 'enhertu', 'destinybreast04']
destinybreast04 showing enhertu benefit in her2-low advanced breast cancer patients gets rare standing ovation at #asco22 
Journalist: Personalized medicine, genomics, cancer; Managing editor: @PrecOncNews 
https://t.co/t2jQRuYQgf 
@GenomeWeb 
https://t.co/MOrpOLPAKt